Home News About us Comitato scientifico Iscriviti Utenti Etica Contenuti Guida Faq Stage Contatti ☰
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Litio

Carbolithium e altri

Bibliografia - Quali fonti bibliografiche per Litio?

  1. Adam-Manes J. et al., J Clin. Pharmacol Ther., 2006, 31 (4), 397.
  2. Aggarwal S.P. et al., Lancet Neurol., 2010, 9 (5), 481.
  3. Agenzia Italiana del Farmaco – AIFA, Resilient – riassunto caratteristiche di Prodotto, 2017, 21 marzo.
  4. Ahmad S., Cardiovasc. Drugs Ther., 1995, 9 (6), 827.
  5. Andén N.E. et al., Lancet, 1973, 2 (7820), 93.
  6. Austin M., Br. J. Psychiatry, 1991, 159, 510.
  7. Baldessarini R.J., Tohen M., Psychopharmacology: Current Trends, 1988, 130.
  8. Baldessarini R.J. et al., Bipolar Disorder Through the Life-Cycle, 1995.
  9. Baldwin C.M., Safferman A.Z., DICP, 1990, 24 (10), 946.
  10. Ballin A. et al., Br. J. Haematology, 1998, 100, 219.
  11. Becker D., J. Clin. Psychiatry, 1989, 50, 473.
  12. Bendz H. et al., Kidney Int., 2010, 77 (3), 219.
  13. Bertschy G. et al., Eur. Psychiatry, 2003, 18, 314.
  14. Binder E.F. et al., Arch. Intern. Med., 1991, 151 (2), 373.
  15. Bloom F.E. et al., Neuropharmacology, 1983, 22, 359.
  16. Bruun N.E. et al., Clin. Sci. (Lond.), 1988, 75 (6), 609.
  17. Burgess S. et al., Cochrane Database Syst. Rev., 2001, (3), CD003013.
  18. Calabrese J.R. et al., J. Clin. Psychiatry, 2003, 64 (9), 1013.
  19. Chiò A. et al., Neurology, 2010, 75 (7), 619.
  20. Cooper S.J. et al., Br. J. Clin. Pharmacol., 1984, 18 (1), 21.
  21. Crossley N.A., Bauer M., J. Clin. Psychiatry, 2007, 68 (6), 935.
  22. Danion J.M. et al., Encephale, 1987, 13 (4), 255.
  23. DasGupta K. et al., J. Clin. Psychiatry, 1992, 53 (11), 398.
  24. Davies B., Australian and New Zeland J. Psychiatry, 1999, 1983, 33s32.
  25. Denicoff K.D. et al., J. Clin. Psychiatry, 1997, 58, 470.
  26. Desvilles M. et al., Nouvelle Press Med., 1982, 11, 3267.
  27. Dickstein G. et al., Am. J. Med., 1997, 102, 454.
  28. Farmaci e gravidanza, AIFA - Ministero della Salute, 2005.
  29. Finley P.R. et al., J. Clin. Psychopharmacol., 1996, 16 (1), 68.
  30. Fornai F. et al., PNAS, 2008, 105 (6), 2052.
  31. Francis G.J. et al., J. Am. Acad. Dermatol., 2001, 44 (2), 308.
  32. Gardon P.H. et al., J. Clin. Psychopharmacol., 1997, 17, 55.
  33. Gelenberg A.J., NEJM, 1989, 321, 1489.
  34. Giles J.J. et al., Arch. Toxicol., 1997, 71,519.
  35. Giles J.J., Bannigan J.G., Curr. Pharm. Des., 2006, 12 (12), 1531.
  36. Goggans F.C., Am. J. Psychiatry, 1980, 137 (7), 860.
  37. Goldberger Z.D., Am J. Psychiatry, 2007, 164, 831.
  38. Goodnick P.J. et al., Expert Opin. Pharmacother., 2002, 3, 479.
  39. Goodwin G.M. et al., J. Psychopharmacol., 2003, 17 (2), 149.
  40. Goodwin G.M. et al., J. Clin. Psychiatry, 2004, 65 (3), 432.
  41. Gracious B.L. et al., J. Am. Acd. Child. Adolesc. Psyhiatry, 1999, 38 (9), 1069.
  42. Hager E.D. et al., J. Trace. Elem. Med. Biol., 2002, 16 (2), 91.
  43. Hanna M.E. et al., J. Clin. Psychopharmacol., 1990, 10, 379).
  44. Hansen E.H., Drugs, 1981, 22, 461.
  45. Hampton P.J. et al., J. Cell Physiol., 2011, 15. doi: 10.1002/jcp.22872.
  46. Jacobson S.J. et al., Lancet 1992, 229, 530.
  47. Jefferson J.W., JAMA, 1979, 241, 1134.
  48. Joffe R. T. et al., Arch. Gen. Psychiatry, 1993, 50, 387.
  49. Juurlink D.N. et al., J. Am. Geriatr. Soc., 2004, 52 (5), 794.
  50. Kallén B., Tandberg A., Acta, Psychiatr. Scand., 1983, 68 (2), 134.
  51. Khan A.U. et al., General Hospital Psychiatry, 1997, 19, 150.
  52. Lovaste R. et al., Riv. Farmacol. Terapia, 1984, 15, 33.
  53. MacCallum W.A., BMJ, 1980, 280 (6214), 610.
  54. Mangano W.E. et al., Clin. Neuropathology, 1997, 16, 30.
  55. Manzoni G.C. et al., Cephalalgia, 1983, 3, 109.
  56. Mekler G., Woggon B., Pharmacopsychiatry, 1997, 30 (6), 272.
  57. Mester R. et al., Biol. Psychiatry, 1995, 37, 348.
  58. Meyer J.M. et al., Int. Clin. Psychopharmacol., 2005, 20 (2), 115.
  59. Miller R.G. et al., Neurology, 2011, 77 (10), 973.
  60. Newport D.J. et al., Am. J. Psychiatry, 2005, 162 (11), 2162.
  61. NICE, National Institute for Health and Clinical Excellence, Depression - The treatment and management of depressione in adults, 2009, ottobre.
  62. Nishimura H. et al., Psychiatry & Clin. Neuroscience, 1997, 51, 411.
  63. Patki A.H., Int. J. Dermatol., 1992, 31 (5), 368.
  64. Ragheb M., J. Clin. Psychopharmacol., 1990, 10 (2), 149.
  65. Reiss R.A. et al., Clin. Pharmacol. Ther., 1994, 55 (4), 392.
  66. Saper J. R., Neurol. Clin., 1989, 7, 387.
  67. Sharman E.J. et al., J. Toxicol.-Clin. Toxicol., 1997, 35, 601.
  68. Shimizu M. et al., J. Clin. Pathology, 1997, 50, 172.
  69. Sitsen J.M. et al., J. Psychopharmacol., 2000, 14 (2), 172.
  70. Snedkova L.V. et al., Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova. 1997, 97(10), 35.
  71. Sobanski T. et al., Pharmacopsychiatry, 1997, 30, 106.
  72. Spring G.K. et al., J. Clin. Psychiatry, 1979, 40 (3), 135.
  73. Spring G.K., Am. J. Psychiatry, 1983, 140 (9), 1257.
  74. Srebrnik A. et al., Cutis, 1991, 48 (1), 65.
  75. Steele T.H. et al., Am. J. Med. Sciences, 1975, 269, 349.
  76. Steiner T.J. et al., Cephalalgia, 1997, 17, 673.
  77. Teicher M.H. et al., JAMA, 1987, 257 (24), 3365.
  78. Tondo L. et al., Acta Psychiatr. Scand., 2001, 104 (3), 163.
  79. Treiser S.L. et al., Science, 1981,213,1529.
  80. Troy S.M. et al., J. Clin. Pharmacol., 1996, 36 (2), 175.
  81. Valdiserri E.V. et al., 1985, J. Clin. Psychiatry, 1985, 46 (12), 540.
  82. van der Lugt N.M. et al., Early Hum. Dev., 2011, 13 ottobre.
  83. Wakelin S.H. et al., Clin. Exp. Dermatol., 1996, 21 (4), 296.
  84. Yacobi S., Ornoy A., Isr. J. Psychiatry Relat. Sci., 2008, 45 (2), 95.
  85. Yassa R., CMAJ, 1986, 134 (2), 141.